Takeo S, Hayashi M, Tanonaka K, Yamamoto K
Department of Pharmacology, Tokyo College of Pharmacy, Japan.
J Pharmacol Exp Ther. 1991 Jul 1;258(1):94-102.
The present study was undertaken to elucidate the possible actions of yohimbine on cardiac function and metabolism in the hypoxic and subsequently reoxygenated myocardium. For this purpose, rabbit hearts were perfused for 20 min under hypoxic conditions, followed by 45 min reoxygenated perfusion, and their functional and metabolic alterations with and without yohimbine treatment were examined. Hypoxia induced cessation of cardiac contractile force, rise in resting tension and depletion of tissue high-energy phosphates, which were poorly recovered by subsequent reoxygenation. Hypoxia also induced release of creatine kinase and ATP metabolites from perfused hearts and increases in tissue calcium and sodium contents, which were further enhanced upon subsequent reoxygenation. When hypoxic hearts were treated with 3 to 30 microM yohimbine, several beneficial effects were observed in a concentration-dependent manner. This included enhancement of posthypoxic recovery of contractile function and suppression of the hypoxia- and reoxygenation-induced rise in resting tension. Hypoxia/reoxygenation-induced release of ATP metabolites was inhibited and restoration of myocardial high-energy phosphates enhanced. Inhibition of reoxygenation-induced rise in tissue calcium and sodium and creatine kinase release were also noted. The findings suggest that suppression of transmembrane flux of ions, substrates and enzymes during hypoxia/reoxygenation plays a role in the posthypoxic functional and metabolic recovery. Yohimbine (3-30 microM) significantly depressed the maximal stimulus frequency the left atria could follow. These results suggest a close relationship between depression in the maximal driving frequency of atria and enhancement of the posthypoxic contractile and metabolic recovery of perfused hearts.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在阐明育亨宾对缺氧及随后复氧心肌的心脏功能和代谢的可能作用。为此,对兔心脏进行20分钟的缺氧灌注,随后进行45分钟的复氧灌注,并检测有无育亨宾处理时心脏的功能和代谢变化。缺氧导致心脏收缩力停止、静息张力升高以及组织高能磷酸盐耗竭,随后的复氧难以使其恢复。缺氧还导致灌注心脏释放肌酸激酶和ATP代谢产物,并使组织钙和钠含量增加,复氧后进一步增强。当用3至30微摩尔的育亨宾处理缺氧心脏时,观察到了几种浓度依赖性的有益作用。这包括增强缺氧后收缩功能的恢复以及抑制缺氧和复氧诱导的静息张力升高。抑制了缺氧/复氧诱导的ATP代谢产物释放,并增强了心肌高能磷酸盐的恢复。还注意到抑制了复氧诱导的组织钙、钠升高以及肌酸激酶释放。这些发现表明,缺氧/复氧期间离子、底物和酶的跨膜通量抑制在缺氧后功能和代谢恢复中起作用。育亨宾(3 - 30微摩尔)显著降低了左心房能够跟随的最大刺激频率。这些结果表明心房最大驱动频率的降低与灌注心脏缺氧后收缩和代谢恢复的增强之间存在密切关系。(摘要截断于250字)